06.42.28.94.90

Les références scientifiques
en apithérapie moderne

Les articles scientifiques

Les news en apithérapie

Articles sur l'apithérapie

Liste des études scientifiques

Abeille liste des études scientifiques

  1. EFSA. – Beeswax (E901) as a glazing agent and a carrier for flavours. Scientific opinion of the pane on food additives, flavourings, processing aids and materials in contact with food (AFC). (2007)
  2. Tomczyk, M.; Zaguła, G.; D˙zugan, M. A simple method of enrichment of honey powder with phytochemicals and its potential application in isotonic drink industry. (2020)
  3. Fratini, F.; Cilia, G.; Turchi, B.; Felicioli, A. Beeswax: A minireview of its antimicrobial activity and its application in medicine. (2016)
  4. C. Nonotte-Varly. Les pollens allergisants de la gelée royale d’origine française. Revue française d’allergologie (2022)
  5. Almeida-Muradian et al. (2005). Chemical composition and botanical evaluation of dried bee pollen pellets.
  6. Anjos, O. et al. (2019). Influence of the storage conditions on the quality of bee pollen.
  7. Bakour, M. et al. (2019). Bee bread as a functional product: Chemical composition and bioactive properties.
  8. Cagno, R. et al. (2019). Novel solid-state fermentation of bee-collected pollen emulating the natural fermentation process of bee bread.
  9. Disayathanoowat, T et al. (2020). Different Dynamics of Bacterial and Fungal Communities in Hive-Stored Bee Bread and Their Possible Roles : A Case Study from Two Commercial Honey Bees in China.
  10. Jaya, F. et al. (2020). Antioxidant activity and microbiological quality of bee bread collected from three different species honey bee.
  11. Kieliszek, M. et al. (2018). Pollen and bee bread as new health-oriented products.
  12. Mohammad et al. (2020). Botanical Origin and Nutritional Values of Bee Bread of Stingless Bee (Heterotrigona itama) from Malaysia.
  13. Mohammad et al. (2021). Stingless Bee-Collected Pollen (Bee Bread) : Chemical and Microbiology Properties and Health Benefits.
  14. Vásquez, A., Olofsson, T. C. (2009). The lactic acid bacteria involved in the production of bee pollen and bee bread.
  15. Khalifa et al., 2020. Recent insights into chemical and pharmacological studies of bee bread.
  16. Rodica Mărgăoan 2019. Bee Collected Pollen and Bee Bread: Bioactive Constituents and Health Benefits.
  17. Castro H.J. – A phase I study of the safety of honeybee venom extract as a possible treatment for patients with progressive forms of multiple sclerosis. (2005)
  18. Ali, M.A.A.S.M. – Studies on bee venom and its medical uses (2012)
  19. Rady, I. et al. – Mellitin, a major peptide component of bee venom, and its conjugates in cancer therapy. (2017)
  20. Abdela, N. et aL. – Bee Venom and its Therapeutic Values (2016)
  21. Pucca, M.B.et al. – Current knowledge on bee venom and bee envenoming therapy. (2019)
  22. Magrioti, V.; Kokotos, G. – Phospholipase A2 inhibitors as potential therapeutic agents for the treatment of inflammatory diseases. (2010)
  23. Cherniack, E.P.; Govorushko, S. – To bee or not to bee : The potential efficacy and safety of bee venom acupuncture in humans. (2018)
  24. Jang, S.B.; Kim, K.H. – Clinical effectiveness and adverse events of bee venom therapy : A systematic review of randomized controlled trials. (2020)
  25. Lee, E.J.; Ahn, Y.C.; Kim, Y.I.; Oh, M.S.; Park, Y.C.; Son, C.G. – Incidence Rate of Hypersensitivity Reactions to Bee-Venom Acupuncture. (2020)
  26. Weis, W.A.; Ripari, N.; Conte, F.L.; da Silva Honorio, M.; Sartori, A.A.; Matucci, R.H.; Sforcin, J.M. – An overview about apitherapy and its clinical applications. (2022)
  27. Kim, K.; Jeong, H.; Lee, G.; Jang, S.; Yook, T. – Characteristics of Adverse Events in Bee Venom Therapy Reported in South Korea: A Survey Study. (2022)
  28. Hwang, Y.J.; Lee, B.C. – Clinical study of anaphylaxis on bee-venom acupuncture. (2000)
  29. Dhopeshwarkar, N.; Sheikh, A.; Doan, R.; Topaz, M.; Bates, D.W.; Blumenthal, K.G.; Zhou, L. – Drug-induced anaphylaxis documented in electronic health records. (2019)
  30. Burdock GA. – Review of the biological properties and toxicity of bee propolis (1998)
  31. S VKL. – Propolis in dentistry and oral cancer management. ( 2014)
  32. Khurshid Z, Naseem M, Zafar MS, Najeeb S, Zohaib S. – Propolis : A natural biomaterial for dental and oral healthcare (2017)
  33. Wilcko WM, Wilcko T, Bouquot JE, Ferguson DJ. – Rapid orthodontics with alveolar reshaping : two case reports of decrowding (2001)
  34. Raghukumar R, Vali L, Watson D, Fearnley J, Seidel V. – Antimethicillin resistant Staphylococcus aureus (MRSA) activity of « pacific propolis » and isolated 53 prenylflavanones. (2010)
  35. Huleihel M, Isanu V. – Anti-herpes simplex virus effect of an aqueous extract of Propolis (2002)
  36. Ito J, Chang FR, Wang HK, Park YK, Ikegaki M, Kilgore N, et al. – Anti-HIV activity of moronic acid derivatives and the new melliferonerelated triterpenoid isolated from Brazilian propolis. (2001)
  37. Harish Z, Rubinstein A, Golodner M, Elmaliah M, Mizrachi Y. – Suppression of HIV-1 replication by propolis and its immunoregulatory effect. (1997)
  38. Siqueira ABS, Rodriguez LRN de A, Santos RKB, Marinho RRB, Abreu S, Peixoto RF, et al. – Antifungal activity of propolis against Candida species isolated from cases of chronic periodontitis. (2015)
  39. Alves de Lima NC, Ratti BA, Souza Bonfim Mendonça P de, Murata G, Araujo Pereira RR, Nakamura CV, et al. – Propolis increases neutrophils response against Candida albicans through the increase of reactive oxygen species. (2018)
  40. Borrelli F, Maffia P, Pinto L, Ianaro A, Russo A, Capasso F, et al. – 54 Phytochemical compounds involved in the anti-inflammatory effect of propolis extract. (2002)
  41. Chan GC-F, Cheung K-W, Sze DM-Y. – The immunomodulatory and anticancer properties of propolis. (2013)
  42. Wu J, Omene C, Karkoszka J, Bosland M, Eckard J, Klein CB, et al. – Caffeic acid phenethyl ester (CAPE), derived from a honeybee product propolis, exhibits a diversity of anti-tumor effects in pre-clinical models of human breast cancer. (2011)
  43. Chuu C-P, Lin H-P, Ciaccio MF, Kokontis JM, Hause RJ, Hiipakka RA, et al. – Caffeic acid phenethyl ester suppresses the proliferation of human prostate cancer cells through inhibition of p70S6K and Akt signaling networks. (2012)
  44. Chen M-F, Wu C-T, Chen Y-J, Keng PC, Chen W-C. – Cell killing and radiosensitization by caffeic acid phenethyl ester (CAPE) in lung cancer cells. (2004)
  45. Kuo Y-Y, Jim W-T, Su L-C, Chung C-J, Lin C-Y, Huo C, et al. – Caffeic Acid Phenethyl Ester Is a Potential Therapeutic Agent for Oral Cancer. (2015)
  46. Bretz WA, Chiego DJ, Marcucci MC, Cunha I, Custódio A, Schneider LG. – Preliminary report on the effects of propolis on wound healing in the dental pulp. (1998)
  47. Arenberger P, Arenbergerova M, Hladíková M, Holcova S, Ottillinger B. – Comparative Study with a Lip Balm Containing 0.5% Propolis Special Extract GH 2002 versus 5% Aciclovir Cream in Patients with Herpes Labialis in the Papular/Erythematous (2018)
  48. Mazia RS, de Araújo Pereira RR, de Francisco LMB, Natali MRM, Dias Filho BP, Nakamura CV, et al. – Formulation and Evaluation of a Mucoadhesive Thermoresponsive System Containing Brazilian Green Propolis for the Treatment of Lesions Caused by Herpes Simplex Type I. (2016)
  49. Curra M, Soares Junior LAV, Martins MD, Santos PS da S. – Chemotherapy protocols and incidence of oral mucositis. An integrative review. (2018)
  50. Piredda M, Facchinetti G, Biagioli V, Giannarelli D, Armento G, Tonini G, et al. – Propolis in the prevention of oral mucositis in breast cancer patients receiving adjuvant chemotherapy : A pilot randomised controlled trial. (2017)
  51. Eslami H, Pouralibaba F, Falsafi P, Bohluli S, Najati B, Negahdari R, et al. – Efficacy of Hypozalix spray and propolis mouthwash for prevention of chemotherapyinduced oral mucositis in leukemic patients: A double-blind randomized clinical trial. (2016)
  52. Joshy A, Doggalli N, Patil K, Kulkarni PK. – To Evaluate the Efficacy of Topical Propolis in the Management of Symptomatic Oral Lichen Planus : A RandomizedControlled Trial. (2018)
  53. Salehi M, Motallebnejad M, Moghadamnia AA, Seyemajidi M, Khanghah SN, Ebrahimpour A, et al. – An Intervention Airing the Effect of Iranian Propolis on Epithelial Dysplasia of the Tongue : A Preliminary Study. (2017)
  54. Burdock GA. – Review of the biological properties and toxicity of bee propolis (1998)
  55. S VKL. – Propolis in dentistry and oral cancer management. ( 2014)
  56. Khurshid Z, Naseem M, Zafar MS, Najeeb S, Zohaib S. – Propolis : A natural biomaterial for dental and oral healthcare (2017)
  57. Oliveira AV, Ferreira AL, Nunes S, Dandlen SA, Miguel da G da G, Faleiro – Antibacterial activity of propolis extracts from the south of Portugal. (2017)
  58. Wilcko WM, Wilcko T, Bouquot JE, Ferguson DJ. – Rapid orthodontics with alveolar reshaping : two case reports of decrowding (2001)
  59. Raghukumar R, Vali L, Watson D, Fearnley J, Seidel V. – Antimethicillinresistant Staphylococcus aureus (MRSA) activity of « pacific propolis » and isolated 53 prenylflavanones. (2010)
  60. Huleihel M, Isanu V. – Anti-herpes simplex virus effect of an aqueous extract of Propolis (2002)
  61. Ito J, Chang FR, Wang HK, Park YK, Ikegaki M, Kilgore N, et al. – Anti-HIV activity of moronic acid derivatives and the new melliferonerelated triterpenoid isolated from Brazilian propolis. (2001)
  62. Harish Z, Rubinstein A, Golodner M, Elmaliah M, Mizrachi Y. – Suppression of HIV-1 replication by propolis and its immunoregulatory effect. (1997)
  63. Siqueira ABS, Rodriguez LRN de A, Santos RKB, Marinho RRB, Abreu S, Peixoto RF, et al. – Antifungal activity of propolis against Candida species isolated from cases of chronic periodontitis. (2015)
  64. Alves de Lima NC, Ratti BA, Souza Bonfim Mendonça P de, Murata G, Araujo Pereira RR, Nakamura CV, et al. – Propolis increases neutrophils response against Candida albicans through the increase of reactive oxygen species. (2018)
  65. Borrelli F, Maffia P, Pinto L, Ianaro A, Russo A, Capasso F, et al. – 54 Phytochemical compounds involved in the anti-inflammatory effect of propolis extract. (2002)
  66. Chan GC-F, Cheung K-W, Sze DM-Y. – The immunomodulatory and anticancer properties of propolis. (2013)
  67. Wu J, Omene C, Karkoszka J, Bosland M, Eckard J, Klein CB, et al. – Caffeic acid phenethyl ester (CAPE), derived from a honeybee product propolis, exhibits a diversity of anti-tumor effects in pre-clinical models of human breast cancer. (2011)
  68. Chuu C-P, Lin H-P, Ciaccio MF, Kokontis JM, Hause RJ, Hiipakka RA, et al. – Caffeic acid phenethyl ester suppresses the proliferation of human prostate cancer cells through inhibition of p70S6K and Akt signaling networks. (2012)
  69. Chen M-F, Wu C-T, Chen Y-J, Keng PC, Chen W-C. – Cell killing and radiosensitization by caffeic acid phenethyl ester (CAPE) in lung cancer cells. (2004)
  70. Kuo Y-Y, Jim W-T, Su L-C, Chung C-J, Lin C-Y, Huo C, et al. – Caffeic Acid Phenethyl Ester Is a Potential Therapeutic Agent for Oral Cancer. (2015)
  71. Bretz WA, Chiego DJ, Marcucci MC, Cunha I, Custódio A, Schneider LG. – Preliminary report on the effects of propolis on wound healing in the dental pulp. (1998)
  72. Arenberger P, Arenbergerova M, Hladíková M, Holcova S, Ottillinger B. – Comparative Study with a Lip Balm Containing 0.5% Propolis Special Extract GH 2002 versus 5% Aciclovir Cream in Patients with Herpes Labialis in the Papular/Erythematous (2018)
  73. Mazia RS, de Araújo Pereira RR, de Francisco LMB, Natali MRM, Dias Filho BP, Nakamura CV, et al. – Formulation and Evaluation of a Mucoadhesive Thermoresponsive System Containing Brazilian Green Propolis for the Treatment of Lesions Caused by Herpes Simplex Type I. (2016)
  74. Curra M, Soares Junior LAV, Martins MD, Santos PS da S. – Chemotherapy protocols and incidence of oral mucositis. An integrative review. (2018)
  75. Piredda M, Facchinetti G, Biagioli V, Giannarelli D, Armento G, Tonini G, et al. – Propolis in the prevention of oral mucositis in breast cancer patients receiving adjuvant chemotherapy : A pilot randomised controlled trial. (2017)
  76. Eslami H, Pouralibaba F, Falsafi P, Bohluli S, Najati B, Negahdari R, et al. – Efficacy of Hypozalix spray and propolis mouthwash for prevention of chemotherapyinduced oral mucositis in leukemic patients: A double-blind randomized clinical trial. (2016)
  77. Joshy A, Doggalli N, Patil K, Kulkarni PK. – To Evaluate the Efficacy of Topical Propolis in the Management of Symptomatic Oral Lichen Planus : A Randomized Controlled Trial. (2018)
  78. Salehi M, Motallebnejad M, Moghadamnia AA, Seyemajidi M, Khanghah SN, Ebrahimpour A, et al. – An Intervention Airing the Effect of Iranian Propolis on Epithelial Dysplasia of the Tongue : A Preliminary Study. (2017)
  79. Abd El Hady F. K, and Hegazi AG., (2002) – Egyptian Propolis : Chemical Composition, Antiviral and Antimicrobial Activities of East Nile Delta Propolis.
  80. Antonio S, Erica W. T, Giuseppina N, Dejair M., (2005) – Origin and Chemical Variation of Brazilian propolis.
  81. Association Française des Enseignants de chimie Thérapeutiques (AFECT)., (2003) – Médicaments antitumoraux et perspectifs dans le traitement des cancers.
  82. Bankova V. S, De Castro S. L, Marcucci M. C., 2000. Propolis: recent advance in chemistry and plant origin.
  83. Bankova V, Popova M, Dogdanov S, Sahatini A G., 2002. Chemical composition of  European propolis : Expected and Unexpected Results.
  84. Bankova V., 2005. Recent trends and important developments in propolis research.
  85. Behling KB,. Se.ndiio M.C, Heloisa D.C. Francescnto .H D.C, Antunes L M.G , Costa R S, .Bianchi M. L. P., 2006. Comparative study of multiple dosage of quercetin against cisplatin-induced nephrotoxicity and oxidative stress in rat kidneys.
  86. Borbulevych O.Y, Jankun J.; Selman S.H., 2004. Skrzypczak-Jankun, E. Lipoxygenase interactions with natural flavonoid, quercetin, reveal a complex with protocatechuic acid in its X-ray structure at a resolution. Proteins.
  87. Conklin KA, et al., 2004. Chemotherapy-associated oxidative stress: impact on chemotherapeutique effectiveness.
  88. Cuvelier C, Iotreppe, Istasse L., 2003. Chimie, sources alimentaires et dosage de la vitamine E.
  89. Fiorucci S., 2006. Activité biologique de composés de la famille des flavonoïdes : approches par des méthodes de la chimie quantique et de dynamique moléculaire.
  90. Ghuysen M.S., 2005. Les médicaments dangereux pour le rein.
  91. Gonwales R, Corcho .l, Remirez D, Rodriguez S, Ancheta 0, Merino N, Gonzales A, and Pascual C., 1995. Hepathoprotective effects of propolis extract on carbon tetrachloride­induced liver injury in rats.
  92. Isla M., Moreno M, Sampitro A, and Vattune M. A., 2001. Antioxdant actvity of argentina propolis extract.
  93. Janero D. R., 1990. Malondaldehyde and thiobar’bituric acid-reactivity as dianostic of lipid peroxydation and peroxydative injury.
  94. Januel C., 2003. Stress oxydant au niveau des plaquettes sanguines humaines dans le contexte du diabète. Etude du glutathion et de la glutathion peroxydase 4.
  95. Katircioglu H and Mercan N., 2006. Antimicrobial activity and chemical compositions of Turkish propolis from different regions.
  96. Kumazawa S, Hamasaka T, Nakayama T., 2004. Antioxidant activity of propolis of various geographic origins.
  97. Lahouel M., 2005. Interaction flavonoides-mitochondrie et rôle de la propolis dans la prévention de l’apoptose induite pat certains médicaments anticancéreux.
  98. Marcucci, M.C. 1995. Propolis : chemical composition, biological properties and therapeutic activity.
  99. Milan H., 2004. La quercetine et ses dérivés : molécules à caractère prooxydant ou capteurs de radicaux libres; études et applications thérapeutiques.
  100. Neiva-Moreno MI. N, Isla M. I, Sampietro A. R, and Vattuone M.A., 2000. Comparaison of the free radical-scavenging activity of propolis from several regions in Argentina.
  101. Sawaya. A. C.H.F, Palma M. A, Caetano F. M, Marcucci M. C, da Silva Cunha I.B, Araujo. CE. P and Shimizu M.T., 2002. Comparative study of in vitro methods used to analyse the activity of propolis extracts with different compositions agains species of Candida.
  102. Sharma M, Pillai K. K, Husain S. Z, Giri D. K.,1997. Protective role of propolis against alcohol carbon tetrachlorde-induced hepatotoxicity in rats.
  103. Sun F, Hayarni S, Haruna S, Ogiri Y, Tanaki K, Yarnada Y, Ikeda K, Yarnada H, Kawai N and Kojo S., 2000. ln vivo antioxydative activity of propolis evaluated by the interaction with vitamin C and vitamin E and the levet of lipid hydroperoxides in rats.
  104. Zhou J., Wang, L, Wang J, Tang, N., 2001. Antioxidative and antitumour activities of solid quercetin metal (II) complexes.
  105. Alvarez-Suarez, J.M., 2017. Bee products – chemical and biological properties.
  106. Tilahun, B., Faust, A.C., McCorstin, P., Ortegon, A., 2015. Nasal colonization and lower respiratory tract infections with methicillin-resistant Staphylococcus aureus.
  107. Silici, S., Kutluca, S., 2005. Chemical composition and antibacterial activity of propolis collected by three different races of honeybees in the same region.
  108. Morroni and Al. – 2018. Comparison of the antimicrobial activities of four honeys from three countries (New Zealand, Cuba, and Kenya).
  109. Alotibi and Al. – 2018. Floral markers and biological activity of Saudi honey.
  110. Chen, Y., Ye, S., Ting, C., Yu, Y. – 2017. Antibacterial activity of propolins from Taiwanese green propolis.
  111. Szczurek, A and Al. – Gas sensor array and classifiers as a means of varroosis detection. Sensors 2020,
  112. Andrzej Szczurek and Monika Maciejewska – 2021 – Beehive Air Sampling and Sensing Device Operation in Apicultural Applications—Methodological and Technical Aspects
  113. W. G. Meikle & N. Holst – 2015 – Application of continuous monitoring of honeybee colonies.
  114. Anna Kurek-Górecka et al. (2020) Bee Products in Dermatology and Skin Care
  115. Goharshenasan P et al. Topical application of honey on surgical wounds – A randomized clinical trial. ( 2016)
  116. Komosinska-Vassev, Ket al. Bee pollen : Chemical composition and therapeutic application. (2015)
  117. Olczyk, P et al. – Propolis modifies collagen types I and III accumulation in the matrix of burnt tissue. (2013)
  118. Hozzein W et al. Topical application of propolis enhances cutaneous wound healing by promoting TGF-beta/smad-mediated collagen production in a streptozotocin-induced type I diabetic mouse model. (2015)
  119. Abouda Z. et al. – The antibacterial activity of Moroccan bee bread and bee pollen (fresh and dried) against pathogenic bacteria. (2011)
  120. Han S.M. – Skin sensitization study of bee venom (Apis mellifera L.) in guinea pigs. (2012)
  121. Kurek-Górecka, A et al. – Structure and antioxidant activity of polyphenols derived from propolis. Molecules (2013)
  122. Olczyk P. et al. – Free radical scavenging activity of drops and spray containing propolis—An EPR examination. (2017)
  123. Isidorov V.A. et al. – Gas chromatographic–mass spectrometric investigation of the chemical composition of beebread. (2009)
  124. Sugiyama T. – Royal jelly acid, 10-hydroxy-trans-2-decenoic acid, as a modulator of the innate immune responses. (2012)
  125. Fratini F. et al. – Beeswax: A minireview of its antimicrobial activity and its application in medicine. (2016)
  126. Son D.J. et al. – Therapeutic application of anti-arthritis, pain-releasing, and anti-cancer effects of bee venom and its constituent compounds. (2007)
  127. Pałgan K. et al. – Biological properties of bee venom. (2009)
  128. Kim H. et al. – Potential therapeutic applications of bee venom on skin disease and its mechanisms (2019)
  129. Han S.M. et al. – Evaluation of the skin phototoxicity and photosensitivity of honeybee venom. (2017)
  130. Kedzia B. et al. – Contemporary opinions on the mechanism of antimicrobial action of honey. (2017)
  131. Nordin A. et al. – Honey epithelial to mesenchymal transition in wound healing (2017)
  132. Minden-Birkenmaier B.A. et al. – Honey-based templates in wound healing and tissue engineering (2018)
  133. Al-Waili N. et al. – Propolis and bee venom in diabetic wounds; a potential approach that warrants clinical investigation. (2015)
  134. Amoros M. et al. – Synergistic effect of flavones and flavonols against herpes simplex virus type 1 in cell culture. Comparison with the antiviral activity of propolis. (1992)
  135. Nolkemper S. et al. – Mechanism of herpes simplex virus type 2 suppression by propolis extracts. (2010)
  136. Peng L. et al. – Antifungal activity and action mode of pinocembrin frompropolis against Penicillium italicum. (2012)
  137. Koo H. et al. – Effects of compounds found in propolis on Streptococcus mutans growth and on glucosyltransferase activity. (2002)
  138. Kedzia B. – Propolis in the treatment of dental caries. (2011)
  139. Bucekova M. et al. – Bee-derived antibacterial peptide, defensin 1, promotes wound re-epithelialisation in vitro and in vivo. (2017)
  140. Kasparaviciene G. et al. – Evaluation of beeswax influence on physical properties of lipstick using instrumental and sensory methods. (2016)
  141. Ahad A. et al. – Chrysin, an anti-inflammatory molecule, abrogates renal dysfunction in type 2 diabetic rats. (2014)
  142. Han S.M. et al. – Effects of cosmetics conatining purified honeybee (Apis mellifera L.) venom on acne vulgaris. (2013)
  143. You C.E. et al. – Effects of emollient containing bee venom on atopic dermatitis : A double-blinded, randomized, base-controlled, multicenter study of 136 patients. (2016)
  144. Prakash S. et al. – Apis cerana bee venom : It’s antidiabetic and anti-dandru activity against malassezia furfur. (2014)
  145. Han S.M. et al. – The beneficial effects of honeybee-venom serum on facial wrinkles in humans. (2015)
  146. Elieh Ali Komi D. et al. – Immunology of Bee Venom. (2018)

Me contacter

    Veuillez sélectionner une catégorie pour cotre message :